Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.9350 (-7.7%) ($2.9350 - $2.9350) on Mon. Mar. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.99% (three month average) | RSI | 57 | Latest Price | $2.9350(-7.7%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CGEN advances 3.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(88%) QQQ(87%) IWO(85%) SKYY(85%) IWM(82%) | Factors Impacting CGEN price | CGEN will decline at least -1.995% in a week (0% probabilities). VXX(-66%) UUP(-35%) TBT(-15%) UNG(-12%) TIP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.995% (StdDev 3.99%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $3.04 | 5 Day Moving Average | $3.15(-6.83%) | 10 Day Moving Average | $3.1(-5.32%) | 20 Day Moving Average | $3.04(-3.45%) | To recent high | -36.5% | To recent low | 6.7% | Market Cap | $243m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |